Speeding up processes to maximise the yield from time-limited patents
The pharmaceutical industry spends vast sums on research and development, trying to develop new molecules or new products. Yet the fact that patents are time limited only leaves a very short marketing window.
That's why marketing processes need to be as effective as possible – the monopoly granted by the patent does not last for ever.
Because G2J videoconferencing and telepresence solutions allow more frequent and more effective interaction, they can speed up decision-making processes and consequently the time-to-market. It is important to bring the product to market as quickly as possible after the patent is granted
Greater reliability, more research
G2J videoconferencing and telepresence solutions are also a way of improving the reliability of tests and clinical trials.
Researchers can collaborate efficiently with doctors and patients, obtaining feedback in real time. Products can be adjusted to minimise side effects and limit the risk to patients.
More efficient testing also means a shorter development phase, which equals lower costs.
Les solutions de vidéoconférence et téléprésence de G2J c’est également l’opportunité de développer la recherche par le biais de partenariats accrus entre laboratoires pour un partage de connaissance et de compétence, pour le plus grand bien être des patients.
